Cargando…

Oxidative Stress, Lipid Profile and Liver Functions in Average Egyptian Long Term Depo Medroxy Progesterone Acetate (DMPA) Users

Depo-medroxy progesterone acetate (DMPA, Depo-Provera(®)) is used in more than 80 countries as a long-acting contraceptive administered as a single intramuscular (i.m) injection of 150 mg/3 months. The present study was set up to investigate the effects of DMPA on 80 average Egyptian women classifie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faddah, L. M., Al-Rehany, M.A., Abdel-Hamid, N. M., Bakeet, A. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2005
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147702/ https://www.ncbi.nlm.nih.gov/pubmed/18007380 http://dx.doi.org/10.3390/10091145

Ejemplares similares

Comparison of Two Different Injectable Contraceptive Methods: Depo-medroxy Progesterone Acetate (DMPA) and Cyclofem
por: Veisi, Firoozeh, et al.
Publicado: (2013)

Comparison of Sexual Dysfunction in Women Using Depo-Medroxyprogesterone Acetate (DMPA) and Cyclofem
por: Ozgoli, Giti, et al.
Publicado: (2015)

Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out
por: Hapgood, Janet P.
Publicado: (2020)

Injectable Depot Medroxy Progesterone Acetate: A Safe Contraceptive Choice in Public Health System of India
por: Gupta, Vikas, et al.
Publicado: (2020)

Protective effect of green tea on tunica adventitia and endothelial changes resulting from depot medroxy progesterone acetate
por: Veri, Nora, et al.
Publicado: (2018)

Depo Medroxyprogesterone (DMPA) Promotes Papillomavirus Infections but Does Not Accelerate Disease Progression in the Anogenital Tract of a Mouse Model
por: Hu, Jiafen, et al.
Publicado: (2022)

Effects of Long-term Use of Depo-medroxyprogesterone Acetate on Lipid Metabolism in Nepalese Women
por: Yadav, Binod Kumar, et al.
Publicado: (2011)

Conjunctival Necrosis due to Subconjunctival Methylprednisolone (Depo-Medrol™) Acetate Injection
por: van Zyl, L. M., et al.
Publicado: (2010)

Single arm phase II trial assessing the safety, compliance with and activity of Bezafibrate and medroxyProgesterone acetate (BaP) therapy against myeloid and lymphoid cancers
por: Murray, Jim, et al.
Publicado: (2019)

Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery
por: Lam, Clarissa, et al.
Publicado: (2016)

Uterine leiomyoma and its association with menstrual pattern and history of depo-medroxyprogesterone acetate injections
por: Amanti, L, et al.
Publicado: (2011)

An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA)()()
por: Katz, Micah, et al.
Publicado: (2020)

Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-Provera
por: Halpern, Vera, et al.
Publicado: (2021)

Depot medroxyprogesterone acetate (DMPA) enhances susceptibility and increases the window of vulnerability to HIV-1 in humanized mice
por: Wessels, Jocelyn M., et al.
Publicado: (2021)

Cost-effectiveness of self-injected DMPA-SC compared with health-worker-injected DMPA-IM in Senegal()()
por: Mvundura, Mercy, et al.
Publicado: (2019)

A comparative study on satisfaction from hormonal contraceptives: depot medroxyprogesterone acetate (DMPA), Cyclofem and LD
por: Fathizadeh, Nahid, et al.
Publicado: (2011)

Scaling up depot medroxyprogesterone acetate (DMPA): a systematic literature review illustrating the AIDED model
por: Curry, Leslie, et al.
Publicado: (2013)

Introduction of Community-Based Provision of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in Benin: Programmatic Results
por: Okegbe, Tishina, et al.
Publicado: (2019)

Evaluating the feasibility and acceptability of self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA) in Senegal: a prospective cohort study()()()
por: Cover, Jane, et al.
Publicado: (2017)

Trends in subcutaneous depot medroxyprogesterone acetate (DMPA-SC) use in Burkina Faso, the Democratic Republic of Congo and Uganda
por: Anglewicz, Philip, et al.
Publicado: (2019)

Designing a global monitoring system for pilot introduction of a new contraceptive technology, subcutaneous DMPA (DMPA-SC)
por: Stout, Anna, et al.
Publicado: (2018)

Incidental Finding of Persistent Hydatidiform Mole in an Adolescent on Depo-Provera
por: Akinlaja, Olukayode, et al.
Publicado: (2016)

Diabetes insipidus in a patient with PCOS treated with Depo-Provera
por: Martinez, Amanda I, et al.
Publicado: (2022)

Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda
por: Anglewicz, Philip, et al.
Publicado: (2021)

Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi
por: Porter Erlank, Chelsey, et al.
Publicado: (2023)

The seahorse (Hippocampus comes L.) extract ameliorates sperm qualities, testosterone level, and serum biochemistry in rats induced by depo medroxyprogesterone acetate
por: Mundijo, Trisnawati, et al.
Publicado: (2023)

The role of partners in promoting self-care for misoprostol and subcutaneous DMPA in Pakistan
por: Uzma, Qudsia, et al.
Publicado: (2021)

Precipitous Delivery Masquerading as Biliary Colic in the Setting of Depo-Provera® Failure
por: Chang, Allen D, et al.
Publicado: (2020)

DMPA-SC stock: Cross-site trends by facility type
por: Magalona, Sophia, et al.
Publicado: (2022)

Genetic polymorphism of estrogen receptor alpha gene in Egyptian women with type II diabetes mellitus
por: Motawi, Tarek M.K., et al.
Publicado: (2015)

Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries
por: Stout, Anna, et al.
Publicado: (2018)

Scale-up of the DMPA-SC in Nigeria: Why policy matters
por: Akinyemi, Oluwaseun, et al.
Publicado: (2022)

Factors Affecting Continued Use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): A Secondary Analysis of a 1-Year Randomized Trial in Malawi
por: Burke, Holly M., et al.
Publicado: (2019)

Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda
por: Odwe, George, et al.
Publicado: (2018)

Effect of DMPA and Molecular Weight of Polyethylene Glycol on Water-Soluble Polyurethane
por: Wondu, Eyob, et al.
Publicado: (2019)

Ulipristal acetate, a progesterone receptor modulator for emergency contraception
por: Jadav, Shilpa P., et al.
Publicado: (2012)

Efficacy and tolerability of 1- and 3-month leuprorelin acetate depot formulations (Eligard(®)/Depo-Eligard(®)) for advanced prostate cancer in daily practice: a Belgian prospective non-interventional study
por: Braeckman, Johan, et al.
Publicado: (2014)

Safety Evaluation of EXPAREL (DepoFoam Bupivacaine) Administered by Repeated Subcutaneous Injection in Rabbits and Dogs: Species Comparison
por: Richard, Brigitte M., et al.
Publicado: (2011)

Enhancing the Enhanced Recovery Program in Colorectal Surgery - Use of Extended-Release Epidural Morphine (DepoDur®)
por: Peravali, Rajeev, et al.
Publicado: (2014)

Changes in body weight and blood pressure among women using Depo-Provera injection in Northwest Ethiopia
por: Zerihun, Muluken Fekadie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_line0shnd98nej9k3f0iogdmnr